ACE2 and viral infectious disease: To mimic authentic virus infection at multiple steps of viral life cycles in nasal and upper airway tracks, we evaluated co-factor usage efficiency in representative variants via pre-treatment of virus-like particles (SC2-VLPs) [33] with various concentrations of free HS prior to infection by using 293T-ACE2-furin cells (Fig. 3A).